Reported Sep 30, 2026 · Ongoing · Updated Oct 6, 2026
Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use…
Amneal Pharmaceuticals of New York, LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Amneal Pharmaceuticals of New York, LLC · 50 Horseblock Rd · Brookhaven, NY · 11719-9509
Is this the product you have?
- Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only
- Manufactured byAmneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India
- Distributed byAmneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
- Lot codes and dates
Lot #: AP250095AExp 2/28/2027
- Amount recalled
- 5,694 pens
Where it was sold
- Nationwide
Why it was recalled
Defective Delivery System: Possibility of no medication in the prefilled pen.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Amneal Pharmaceuticals recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.